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Abstract 
Major depressive disorder (MDD) is associated with decreased heart rate variability 
(HRV), a predictor of cardiovascular morbidity by many, but not all studies. This 
inconsistency could be due to the association of HRV with specific depressive symptoms. 
Here, we investigated the association of HRV parameters with components of depressive 
symptoms from 120 MDD patients, at baseline of a published trial comparing the effect of 
sertraline to transcranial direct current stimulation. We used Principal Component Analysis 
to extract components of the Hamilton Rating Scale for Depression (HAM-D-17), the 
Montgomery Asberg Depression Rating Scale (MADRS) and the Beck Inventory for 
Depressive Symptomatology (BDI). We constructed one equation of multiple linear 
regression for each HRV parameter as the dependent variable, and the components of 
depressive symptoms of the three scales as the independent ones, adjusted for age and 
gender. A component of HAM-D-17 predicted LF/HF (low frequency/high frequency) and 
a component of MADRS predicted LF (low frequency).  “Guilt” and “loss of 
interest/pleasure in activities” were present in the components of both scales, and the 
MADRS component also included “psychomotor retardation”. These results suggest that 
melancholic features might be relevant for the association between MDD and HRV. 
Considering multiple comparisons, these results are preliminary.  
 
Keywords: depressive symptoms; major depressive disorder; heart rate; melancholic 
features; melancholia; cardiovascular disease. 
 
1. Introduction

 
 
Major depressive disorder (MDD) is associated with cardiovascular disease (CVD) 
(Kemp et al., 2015; Kemp and Quintana, 2013). One potential explanation for this 
association is autonomic nervous system dysfunction (Carney et al., 1995), particularly in  
more severe (Kemp et al., 2014c; Stein et al., 2000), and melancholic cases (Kemp et al., 
2014c), which may increase risk for developing CVD, and worsen prognosis for those with 
preexisting CVD (Lichtman et al., 2014). Heart rate variability (HRV), an index of beat-to-
beat variations in heart rate, may reflect the health of the autonomic nervous system such 
that high HRV reflects healthy cardiac function, while low HRV reflects autonomic 
inflexibility, which may, over time, increase the risk for CVD (Kemp and Quintana, 2013; 
Kemp et al., 2012). Low HRV has even been shown to predict future adverse 
cardiovascular events in those without any prior history of CVD (Hillebrand et al., 2013).        
More than two decades ago, it was reported that patients with depression display 
decreased HRV (Carney et al., 1995); since that time, two meta-analyses have reported that 
depression is associated with reductions in HRV, findings associated with a modest effect 
size (Kemp et al., 2010; Rottenberg et al., 2007). However, contradictory data have been 
reported, leading some to suggest that HRV reductions in depression are driven primarily 
by antidepressants (Kemp et al., 2014a; Licht et al., 2008; O'Regan et al., 2015). A possible 
explanation for these inconsistencies might be the complexity of the depressive syndrome, 
which is comprised of multiple symptoms from different domains; some specific 
symptoms may be associated with low HRV, while others may have no relationship with 
HRV (Rottenberg et al., 2007). Consequently, when all the symptoms are evaluated 
simultaneously, the associations of specific symptoms with low HRV may not be 
identified.  
In prior study (Brunoni et al., 2013a), we demonstrated that depressed subjects display 
lower HRV values compared to healthy controls. These patients were assessed at baseline 
in a double blind clinical trial (Brunoni et al., 2013b). Patients displayed reductions in 
various measures of HRV including the Root Mean Square of the Successive Differences 
(RMSSD; t117 = 2.86; p = 0.005; Cohen’s d = 0.35) and High Frequency (HF) HRV (t117 
= 3.77; p < 0.001; Cohen’s d = 0.45) (Brunoni et al., 2013a). In the present study, we 
                                                             
 MDD: major depressive disorder; CVD: cardiovascular disease; HRV: heart rate variability; tDCS: 
transcranial direct current stimulation; RMSSD: root mean square of the successive differences; FFT: 
Fast Fourier Transform; LF: low frequency; HF: high frequency; LF/HF: low frequency/high frequency; 
HAM-D-17: Hamilton Rating Scale for Depression, 17-item version; MADRS: Montgomery Asberg 
Depression Rating Scale; BDI: Beck Depression Inventory. 
investigated whether distinct components of depressive symptoms, in these same patients, 
are differentially associated with changes in HRV. 
 
2. Methods 
2.1 Subjects 
We evaluated data from 120 patients collected during a baseline assessment for 
previously published, double-blind, randomized, controlled clinical trial, designed to assess 
the combined safety and efficacy of tDCS vs. a common pharmacological treatment 
(sertraline hydrochloride, 50 mg/d) for MDD (Brunoni et al., 2013a). Patients were 
antidepressant-free, with moderate to severe, nonpsychotic, unipolar MDD, with low risk 
for cardiovascular disease. Patients were excluded if they had other Axis I disorders, 
including alcohol dependence or harmful substance use (although comorbid anxiety 
disorders were allowed); any Axis II disorders; previous neurological conditions (epilepsy, 
traumatic brain injury, stroke, etc.); any severe, life-threatening Axis III disorders; and 
specific contraindications for tDCS (e.g., metallic plates in the head).  
The study was approved (registration number: 041/16) by the Ethics Committee of the 
University Hospital of the University of Sao Paulo, in accordance with the Helsinki 
Declaration. 
2.2 Procedures 
2.2.1 Depression scales 
Trained researchers assessed depression severity at baseline before starting 
antidepressant treatment. These scales included the 17-item version of the Hamilton Rating 
Scale for Depression (HAM-D-17) (Hamilton, 1960) and the Montgomery Asberg 
Depression Rating Scale (MADRS) (Montgomery and Asberg, 1979). All patients also 
completed the Beck Depression Inventory (BDI) (Beck et al., 1961).  
2.2.2 HRV recording 
To assess HRV, electrocardiography was recorded in a quiet, temperature-controlled 
room set at 22
O
C. A digital electrocardiograph Wincardio (Micromed, Brasilia, Brazil), 
with a sampling rate of 250 Hz, was used to acquire the records. The electrodes were 
placed on the limbs, and the signals were recorded for 15 minutes. We used Wincardio 4.4 
to generate the beat-to-beat R-R interval series from the higher R-wave amplitude lead 
(usually D2). The artifacts and ectopic beats were corrected by the spline cubic 
interpolation.  
The following variables were extracted:  
(a) for the time-domain, we used RMSSD (root mean square of the successive 
differences), which reflects the variance between successive beat-to-beat intervals with 
higher values reflecting higher variability. RMSSD is the most appropriate time-domain 
measure for short-duration ECG recordings (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology, 1996). .   
(b) for the frequency-domain, a Fast Fourier Transform (FFT) method was used. 
Oscillatory components present in the time series were labeled as LF (low frequency, with 
frequencies of 0.04 to 0.15 Hz) and HF (high frequency, with frequencies of 0.15 to 0.4 
Hz) bands. After extracting these parameters, we also calculated the LF/HF ratio, another 
commonly reported measure in the frequency-domain.  
2.3 Statistical analysis 
In order to investigate the association of HRV with specific components of depressive 
symptoms, we first extracted principal components from each scale (HAM-D-17, MADRS 
and BDI) using Principal Components Analysis, including Varimax rotation and Kaiser 
normalization. We established the number of components by a visual analysis of scree 
plots of each scale (Figures 1, 2 and 3). Scores of each component are their factorial 
scores. We constructed equations using multiple linear regression analysis, including all 
components of depressive symptoms from the three scales, gender and age as independent 
variables and one parameter of HRV as the dependent variable. We used a stepwise 
backward procedure to achieve the final model, maintaining variables with p < 0.10. We 
chose the backward procedure given that it tends to be less prone to selection bias due to 
collinearity among the predictors compared to the forward procedure (Hutmacher and 
Kowalski, 2015). We ran this procedure for each parameter of HRV including RMSSD, 
LF, HF and LF/HF ratio. We had considered performing a multivariate analysis including 
all the HRV parameters together. However, we chose to analyze each HRV parameter 
individually, considering that most of these parameters reflect distinct aspects of the 
autonomic system. For example, LF may reflect baroreflex modulation (Goldstein et al., 
2011), while HF reflects parasympathetic activity (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology, 1996). 
We maintained the significance level at p<0.05 and did not correct for multiple 
comparisons; thus, the study should be considered a exploratory. 
 
3. Results 
3.1 Participant characteristics 
Sociodemographic and clinical characteristics of the sample are displayed in Table 1. 
Briefly, our sample comprised 82 women and 38 men (mean age = 42 years, SD=12; 
education = 13.7 years, SD = 4) with depression of moderate severity (HAM-D-17 mean 
score = 21.8; SD=4). For technical reasons, HRV data were not collected from all 
participants; HRV measures were obtained from a total of 118 patients. 
3.2 Components of depressive symptoms 
Based on the Scree plot we found six components in the HAM-D-17, two 
components in the MADRS and three in the BDI. The components of the HAM-D-17 
were: a) Component 1 (“sleep”): item 4 (early insomnia), item 5 (middle insomnia) and 
item 6 (late insomnia); b) Component 2 (“somatic anxiety”): item 11 (somatic anxiety) and 
item 15 (hypochondria); c) Component 3 (“weight”): item 12 (somatic symptoms) and item 
16 (loss of weight); d) Component 4 (“core symptoms”): item 1 (depressed mood), item 2 
(feelings of guilt), item 3 (suicidal thoughts) and item 7 (work and activities); e) 
Component 5 (“somatic agitation”): inverse relationship between item 9 (agitation) and 
item 13 (general somatic symptoms); f) Component 6 (“genital”): item 14 (genital 
symptoms).  
The components of the MADRS were: a) Component 1 (“mood”): item 1 (apparent 
sadness), item 2 (reported sadness), item 3 (inner tension) and item 9 (pessimistic 
thoughts); b) Component 2 (“anhedonia- retardation”): item 6 (concentration difficulties), 
item 7 (lassitude), item 8 (inability to feel) and item 9 (pessimistic thoughts).  
Finally, the components of the BDI were: a) Component 1 (“mood-anhedonia”): 
item 1 (sadness), item 2 (pessimism), item 3 (failure), item 4 (loss of pleasure), item 12 
(loss of interest), item 13 (indecisiveness), item 15 (loss of energy), item 17 (irritability); 
b) Component 2 (“negative self-image”): item 3 (failure), item 5 (guilty feelings), item 6 
(punishment feelings), item 7 (self-dislike), item 8 (self-criticalness), item 9 (suicidal 
thoughts or wishes), item 10 (crying), item 11 (agitation) and item 14 (worthlessness); c) 
Component 3 (“general physical”): item 16 (changes in sleeping pattern), item 18 (changes 
in appetite), item 20 (tiredness or fatigue) and item 21 (loss of interest in sex). 
3.3 Association between depressive symptom components and HRV parameters 
After controlling for age and gender, multiple linear regression analysis revealed that 
LF was predicted by component 4 of the HAM-D-17 (i.e. “core symptoms” including: 
depressed mood, feelings of guilt, suicidal thoughts and lack of disposition for work and 
other activities), and LF/HF ratio by component 2 of the MADRS (i.e. “anhedonia- 
retardation” including lack of concentration, lassitude, and pessimistic thoughts). The BDI 
did not predict any HRV parameter (Table 2). 
  
4. Discussion 
Here we show that depressive symptoms in the HAM-D-17 (i.e. component “core 
symptoms” including depressed mood, feelings of guilt, suicidal thoughts and lack of 
disposition for work and other activities) predict the LF HRV component, while depressive 
symptoms in the MADRS (i.e. component “anhedonia- retardation” including lack of 
concentration, lassitude, inability to feel, and pessimistic thoughts) predict the LF/HF ratio. 
These results support the concept that HRV is associated with some depressive symptoms, 
but not with all (Rottenberg et al., 2007).  
4.1 Components of depressive symptoms, melancholic features and HRV 
HRV was associated with components of symptoms including “loss of 
interest/pleasure” and “guilt”; symptoms considered to be melancholic by the Manual of 
Diagnostic and Statistics of Mental Disorders of the American Psychiatric Association 
(DSM – 5). Reinforcing their potential relevance, “loss of interest/pleasure” and “guilt” 
were present in the component from HAM-D-17 as well as the component from MADRS. 
Furthermore, the MADRS component associated with HRV also include the symptom 
“psychomotor retardation”, another characteristic of melancholia. In line with our findings, 
melancholic features have previously been related to HRV parameters and poor 
cardiovascular prognosis. For example, anhedonia (loss of interest/pleasure) has been 
reported to be a predictor of cardiovascular events (Leroy et al., 2010) and to be associated 
with increased sympathetic sensitivity during pregnancy (Pearson et al., 2012);  guilt, in 
normal volunteers has been associated with prolonged cardiac sympathetic arousal as 
measured by pre-ejection period (PEP) (Fourie et al., 2011). Another melancholic 
symptom, late insomnia, assessed by daily diary measures of late insomnia has been 
reported to have an inverse association with Cardiac Vagal Control, which is based on HF 
HRV (Rottenberg et al., 2007).  
Considering diagnosis instead of symptoms,  an earlier study reported that melancholic 
depressed patients, had higher HR, but not HF HRV (respiratory sinus arrhythmia)  relative 
to non-depressed controls (Moser et al., 1998). The increase in heart rate found in their 
melancholic patients, was explained as a possible reflex of increased sympathetic 
autonomic system or an increased autonomous heart rate (Moser et al., 1998). Similarly, a 
recent study investigating the impact of melancholia over HR and HRV, compared to non-
melancholia and control, found that melancholic patients had increased HR relative to non-
melancholic ones and healthy controls (Kemp et al., 2014c); while measures of HF HRV in 
melancholic patients were decreased relative to healthy controls, but not to non-
melancholic patients (Kemp et al., 2014c). An explanation for these findings could be that 
vagal function (reflected by HF HRV) distinguishes melancholic patients from healthy 
controls, while non-vagal components of heart rate may distinguish disorder subtypes (i.e. 
melancholia versus non-melancholia) (Kemp et al., 2014c).  
Considering the cross-sectional nature of our study, it is not possible to know whether 
depressive symptoms lead to changes in HRV/dysfunctional autonomic function, or 
changes in HRV/dysfunctional autonomic function leads to depression. Traditionally, 
depression has been considered the predictor for changes in HRV/dysfunctional autonomic 
function. However, HRV at baseline, have predicted incident depressive symptoms at 
follow-up, indicating that both directions may exist (i.e. melancholic symptoms were not 
analyzed separately) (Jandackova et al., 2016).  
4.2 Components of depressive symptoms, non-melancholic features and HRV 
Of relevance, considering non-melancholic symptoms, the HAM-D-17 component that 
predicted LF, included suicidal thoughts. Prior study has revealed  associations between 
suicidality and respiratory sinus arrhythmia (Rottenberg et al., 2002). Suicidality has been 
related to the capacity of dealing with stress. Depressed women with suicidal attempt, 
while submitted to the Trier Social Stress Test, showed lower HF HRV compared to 
depressed women without suicidal attempt, indicating reduced capacity to regulate 
response to stress in those with suicidal attempt  (Wilson et al., 2016). Also, an absence of 
SSRIs’ effect on vagal system under stress, while starting antidepressant treatment in 
adolescents, may be an explanation for suicidality in this population (Kemp et al., 2014b). 
On this matter, stress has been shown to increase HR and decrease HF HRV, effects that 
may be influenced by escitalopram, depending on the age of patients (Kemp et al., 2014b). 
In adults aged 25 years and above, escitalopram has increased HF HRV at rest, but not at 
stress  and decreased HR at rest and attenuated the increase on HR under stress; effects that 
had not occurred in those under 25 years. Thus, in young patients, SSRIs would not lead to 
a benefit on dealing with stress by attenuating the reduction of vagally mediated response 
to stress, assessed by the absence of attenuating the increase in HR under stress (Kemp et 
al., 2014b). Considering the association between reduced vagal response and suicide 
attempt mentioned above (Wilson et al., 2016), such lack of preserving the vagally 
mediated response to stress could be related to the increase in suicidality in depressed 
young patients starting a SSRI treatment. Our results showing the association between LF 
HRV and suicidal ideation support that this relationship might also be mediated by non-
vagal mechanisms. Little is known regarding the direction of this relationship, if increased 
suicidality leads to changes in HRV/autonomic system or a dysfunctional HRV/ autonomic 
system leads to an increase in suicidality. Lower cardiovascular fitness at age of 18 years 
has been prospectively associated with an increased risk of suicide attempt or death by 
suicide in adulthood (Aberg et al., 2014), suggesting that the direction might be the 
autonomic system acting on suicidality. Additionally, the association between high resting 
HR and suicide may also be explained by sharing biological mechanisms, such as genetic 
factors or neural determinants (Lemogne et al., 2011).  
Contrasting with our findings regarding the inclusion of suicidal thoughts -a 
psychological symptom- in one of the components of depressive symptoms related to 
HRV, de Jonge et al. found an association of low HRV parameters (SDNN, LF, and HF) 
with  a group of somatic depressive symptoms (sleeping difficulties, fatigue and appetite 
problems), but not with cognitive ones (de Jonge et al., 2007). This contrast may be 
explained by the fact that, although being psychological, suicidal thoughts was in a HAM-
D-17 component including the core symptoms of depression (i.e. depressed mood and 
anhedonia) and melancholic features (i.e. anhedonia and feelings of guilt)  (de Jonge et al., 
2007). Intriguingly, the associations with LF were in the opposite directions, in our study 
higher scores on the component 2 of MADRS predicted higher LF, whereas in the de Jonge 
et al. study, somatic symptoms were associated with low LF (de Jonge et al., 2007). Such 
discrepancy may be explained if we consider that LF may reflect a mix of sympathetic and 
parasympathetic activity (Bassett, 2016). In line with this view, the relationship of 
depression with LF has diverged among the studies;  it has been reported to be associated 
with low LF (Yeh et al., 2016), and with high LF (Wang et al., 2013).  
In our sample, the depressive components that predicted HRV did not include anxiety 
related and sleep related symptoms. Besides late insomnia, as commented above 
(Rottenberg et al., 2007), HRV has been related to other sleep symptoms. Increased scores 
on subjective sleep quality assessed with the Pittsburgh Sleep Quality Index were 
positively correlated with increased LF/HF ratio in subjects with MDD (Yang et al., 2011). 
Regarding anxiety symptomatology, anxiety has been associated with decreased baroreflex 
sensitivity, which is a reflex of lower parasympathetic activity and a predictor of 
cardiovascular mortality (Virtanen et al., 2003). This contrast with our results suggests that 
differences in methods, samples, presence of moderators and other factors including 
comorbidities (i.e. potential confounders) may influence the results. A topic that deserves 
future studies.  
4.3 Components of depressive symptoms not relevant for HRV  
In our patients, most components of depressive symptoms were not associated with 
HRV. Previously, studies have reported an absence of relationship between some 
depressive symptoms and HRV. For example, as mentioned above, psychological 
symptoms were not associated with HRV (de Jonge et al., 2007). A cross sectional study to 
determine whether psychological factors (somatization, depression, anxiety, hostility and 
phobicity) were associated with HRV, blood pressure variability and baroreflex sensitivity, 
also found that psychological factors were non-related to HRV (Virtanen et al., 2003). No 
association between HRV and irritability has been found in patients with MDD 
(Verhoeven et al., 2011). As mentioned above, considering that it is an initial study, our 
positive and negative results deserve future confirmation.   
4.4 Clinical and physiological signification of LF and LF/HF ratio 
Various studies have suggested that LF should not be considered as an indicator of 
sympathetic activity and LF/HF ratio should not be considered as an indicator of 
sympathovagal balance. Factors supporting these criticisms include the influence of LF 
peak by factors other than  sympathetic and  parasympathetic system; the existence of 
conditions that may provoke simultaneous increases in sympathetic and parasympathetic 
activity or simultaneous decreases in both systems (i.e. not  always an increase in one and 
decrease in the other autonomic system);  and the relationship between HRV and 
sympathetic and parasympathetic activity is not necessarily linear (Billman, 2013). As 
mentioned above, LF may represent a mix of sympathetic and parasympathetic activity 
(Bassett, 2016). Additionally, studies in humans and animals have indicated that LF and 
LF/HF ratio may be an index of baroreflex function, which in turn could affect cardiac 
autonomic function (Goldstein et al., 2011). Additionally, as pointed out by Reyes del Paso 
et al. (2013),  HRV parameters may reflect diverse information about autonomic regulation 
and be influenced by distinct factors, for example, HF is influenced by respiratory activity; 
and  LF is influenced by blood pressure control mechanisms  (Reyes del Paso et al., 2013). 
Therefore, it might be too early to conclusively designate physiological meanings to LF 
and LF/HF ratio. Notwithstanding, studies continue to support the association of LF/HF 
ratio with depression (Kemp et al., 2012; Kemp et al., 2010) and its value as indicator of 
cardiac morbidity (Davydov et al., 2007). For example, LF/HF ratio was the most 
important predictor of the magnitude of flow-mediated dilation of the brachial artery (i.e. 
an indicator of endothelial function)  in 47 patients with ischemic heart disease (Watanabe 
et al., 2013). Increased values of LF/HF ratio have been associated with complications in 
patients with myocardial infarction (Ablonskytė-Dūdonienė et al., 2013) and also with 
tricyclic intoxication (Dinleyici et al., 2013).  
4.5 Contribution of the study 
Our findings showing that not all depressive symptoms, but only some components, are 
relevant for the relationship with HRV, may be fundamental to the possibility of reverting 
the HRV/autonomic system dysfunction by achieving remission of these components and 
not the current concept of depression remission. For example, the previous reported study 
with our sample, applying the wide used concept of remission based on HAM-D-17 scores 
< 7, revealed that the association of MDD was independent of the state of depression 
(remission versus non-remission)  (Brunoni et al., 2013a). However, remitted patients, 
according to that criteria, may still have residual symptoms of a component that is 
significantly relevant for the relationship with HRV. Consequently, it is possible that the 
reversion of changes in HRV/autonomic system associated with depression could require 
the remission of the specific components of depressive symptoms that are related to HRV. 
4.6 Limitations 
Some limitations of our study should be considered. We used three scales of depression 
instead of only one, and performed several comparisons without correcting the level of 
significance, thus our results should be considered preliminary. Although preliminary, it is 
worth noting that the melancholic symptoms “loss of interest” and “guilt” were present in 
both components that predicted HRV, one from HAM-D-17 and one from MADRS.  
4.7 Conclusions 
Our results support the concept that there might exist an association between HRV and 
some component of depressive symptoms, but not all symptoms. In particular, increased 
LF and LH/HF were predicted by a component of depressive symptoms from HAM-D-17 
and one from MADRS, both characterized by melancholic symptoms and sharing the 
symptoms “loss of interest/pleasure” and “guilt”. If confirmed, our data support the view 
that the presence of melancholic features might place depression as a distinct identifiable 
mood disorder (Parker et al., 2010).  
Future research should consider the relevance of melancholic features and their 
remission on the relationship between HRV parameters and depression.  
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Figure 1. Scree plot HAM-D-17 
Figure 2. Scree plot MADRS 
   
Figure 3. Scree plot, BDI 
 Table 1. Sociodemographic characteristics of the sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HAM-D-17:17-item version of Hamilton Rating Scale for Depression; MADRS: 
Montgomery-Åsberg Depression Rating Scale; BDI: Beck Depression Inventory.   
Numerical variables Mean + SD 
Age, years  42  12 
Years of schooling  13.7  4 
Baseline scores   
MADRS  
 
30.6  6 
HAM-D-17 
 
21.8  4 
BDI  
 
32.7  9 
Clinical Global Impression   
 
4.4  1 
Categorical variables n % 
Women 82  68 
Depression subtypes 
Atypical  
Melancholic  
 
 
63 
31  
 
52 
26 
Treatment-resistant depression   
≤ 1 failed trial 67 56 
> 2 failed trials   
 
26 21 
Clinical comorbidities   
Current smokers   21  17 
Hypothyroidism 16 13 
Hypertension  27 22 
   
Psychiatric comorbidities   
General Anxiety Disorder 60 50 
Social Phobia   15 12 
Panic Disorder 17 14 
Dysthymia 31 26 
Table 2. Relationship between a parameter of HRV and components of depressive symptoms: 
multiple linear regression analysis, adjusted 
 
Dependent variable 
(Parameters of HRV) 
Independent variables 
(Components of depressive 
symptoms) 
 
β 
 
 
 
CI 95% 
 
 
 
p 
 
 
RMSSD Constant  5.53 – 6.59 <0.001 
 HAM-D-17 Component 4 -0.17 -1.11 – 0.04 0.073 
 MADRS Component 2 0.14 -0.08 – 1.08  0.093 
 
LF 
 
Constant 
 
 
 
22.80 – 31.73 
 
<0.001 
 HAM-D-17 Component 4  -0.18 -9.37– 0.45 0.075 
 MADRS Component 2 0.22 0.66 – 10.55 0.029  
     
HF Constant  19.60 – 29.76 <0.001 
 HAM-D-17 Component 4 -0.19 -11.14 – 0.04 0.058 
 MADRS Component 2 0.16 -0.66 – 10.55 0.080 
        
     
LF/HF Constant  1.19 – 1.40 <0.001 
 HAM-D-17 Component 4  0.21  0.01 – 0.23 0.021 
     
HRV: heart rate variability; HAM-D-17:17-item version of Hamilton Rating Scale for Depression; MADRS: Montgomery-Åsberg 
Depression Rating Scale; RMSSD: square root of the mean of squares of diferences between sucessive  NN intervals.  HF: high 
frequency; LF: low frequency; LF/HF: ratio between LF and HF; CI 95%: confidence interval of 95%                                                      
An equation of multiple linear regression analysis was built for each parameter of heart rate variability as the dependent variable and the 
11 components of the depression scales as the independent ones.  The equations were adjusted for age and gender. A Final model was 
achieved using stepwise procedure maintaining variables with significance below 0.10.                                                                             
MADRS Component 2: item 6 (concentration difficulties), item 7 (lassitude), item 8 (inability to feel) and item 9 (pessimistic thoughts). 
HAM-D-17 Component 4: item 1 (depressed mood), item 2 (feelings of guilt), item 3 (suicidal thoughts) and item 7 (work and activities). 
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HIGHLIGHTS 
 
 Heart rate variability may be related with some, but not all, depressive symptoms. 
 Melancholic symptoms may be essential for the relation with heart rate variability. 
 Studying remission of specific depressive symptoms and heart rate variability is 
needed. 
 
 
